Market icon

Will RFK end any vaccine approvals by December 31?

<1% chance
Polymarket

$7,093 Vol.

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
音量
$7,093
終了日
Dec 31, 2025
作成日時
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

提案された結果: No

異議申し立てなし

最終結果: No

外部リンクに注意してください。

Market icon

Will RFK end any vaccine approvals by December 31?

<1% chance
Polymarket

$7,093 Vol.

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
音量
$7,093
終了日
Dec 31, 2025
作成日時
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

提案された結果: No

異議申し立てなし

最終結果: No

外部リンクに注意してください。